» Articles » PMID: 35585057

Involvement of FSP1-CoQ-NADH and GSH-GPx-4 Pathways in Retinal Pigment Epithelium Ferroptosis

Overview
Journal Cell Death Dis
Date 2022 May 18
PMID 35585057
Authors
Affiliations
Soon will be listed here.
Abstract

Retinal pigment epithelium (RPE) degeneration plays an important role in a group of retinal disorders such as retinal degeneration (RD) and age-related macular degeneration (AMD). The mechanism of RPE cell death is not yet fully elucidated. Ferroptosis, a novel regulated cell death pathway, participates in cancer and several neurodegenerative diseases. Glutathione peroxidase 4 (GPx-4) and ferroptosis suppressor protein 1 (FSP1) have been proposed to be two main regulators of ferroptosis in these diseases; yet, their roles in RPE degeneration remain elusive. Here, we report that both FSP1-CoQ-NADH and GSH-GPx-4 pathways inhibit retinal ferroptosis in sodium iodate (SIO)-induced retinal degeneration pathologies in human primary RPE cells (HRPEpiC), ARPE-19 cell line, and mice. GSH-GPx-4 signaling was compromised after a toxic injury caused by SIO, which was aggravated by silencing GPx-4, and ferroptosis inhibitors robustly protected RPE cells from the challenge. Interestingly, while inhibition of FSP1 caused RPE cell death, which was aggravated by SIO exposure, overexpression of FSP1 effectively protected RPE cells from SIO-induced injury, accompanied by a significant down-regulation of CoQ/NADH and lipid peroxidation. Most importantly, in vivo results showed that Ferrostatin-1 not only remarkably alleviated SIO-induced RPE cell loss, photoreceptor death, and retinal dysfunction but also significantly ameliorated the compromised GSH-GPx-4 and FSP1-CoQ-NADH signaling in RPE cells isolated from SIO-induced RPE degeneration. These data describe a distinct role for ferroptosis in controlling RPE cell death in vitro and in vivo and may provide a new avenue for identifying treatment targets for RPE degeneration.

Citing Articles

Sodium Iodate-Induced Ferroptosis in Photoreceptor-Derived 661W Cells Through the Depletion of GSH.

Chen C, Wang H, Yang J, Zhao B, Lei Y, Li H Int J Mol Sci. 2025; 26(5).

PMID: 40076952 PMC: 11900459. DOI: 10.3390/ijms26052334.


Naringin Suppresses CoCl-Induced Ferroptosis in ARPE-19 Cells.

Yang Y, Liu M, Dong X, Bai J, Shi W, Zhu Q Antioxidants (Basel). 2025; 14(2).

PMID: 40002420 PMC: 11852185. DOI: 10.3390/antiox14020236.


Ferroptosis in thyroid cancer: mechanisms, current status, and treatment.

Tian W, Su X, Hu C, Chen D, Li P Front Oncol. 2025; 15:1495617.

PMID: 39917169 PMC: 11798778. DOI: 10.3389/fonc.2025.1495617.


Investigation into the influence of mild hypothermia on regulating ferroptosis through the P53-SLC7A11/GPX4 signaling pathway in sepsis-induced acute lung injury.

Tao L, Xu J, Jiang L, Hu J, Tang Z Intensive Care Med Exp. 2025; 13(1):4.

PMID: 39812923 PMC: 11735705. DOI: 10.1186/s40635-025-00713-3.


Cell-membrane targeting sonodynamic therapy combination with FSP1 inhibition for ferroptosis-boosted immunotherapy.

Chen J, Zhan Q, Li L, Xi S, Cai L, Liu R Mater Today Bio. 2025; 30():101407.

PMID: 39811609 PMC: 11732120. DOI: 10.1016/j.mtbio.2024.101407.


References
1.
Benedetto M, Contin M . Oxidative Stress in Retinal Degeneration Promoted by Constant LED Light. Front Cell Neurosci. 2019; 13:139. PMC: 6499158. DOI: 10.3389/fncel.2019.00139. View

2.
Yang D, So K, Lo A . Lycium barbarum polysaccharide extracts preserve retinal function and attenuate inner retinal neuronal damage in a mouse model of transient retinal ischaemia. Clin Exp Ophthalmol. 2017; 45(7):717-729. DOI: 10.1111/ceo.12950. View

3.
Doll S, Porto Freitas F, Shah R, Aldrovandi M, Costa Da Silva M, Ingold I . FSP1 is a glutathione-independent ferroptosis suppressor. Nature. 2019; 575(7784):693-698. DOI: 10.1038/s41586-019-1707-0. View

4.
Fuchs Y, Steller H . Programmed cell death in animal development and disease. Cell. 2011; 147(4):742-58. PMC: 4511103. DOI: 10.1016/j.cell.2011.10.033. View

5.
Takahashi V, Takiuti J, Jauregui R, Tsang S . Gene therapy in inherited retinal degenerative diseases, a review. Ophthalmic Genet. 2018; 39(5):560-568. DOI: 10.1080/13816810.2018.1495745. View